Abiopharma

🔍 CURTIS JASON TRAVIS (Executive)

Company: U S PHYSICAL THERAPY INC /NV (USPH)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Sold 40 shares of Common Stock at $78.0 per share (Direct)
  Date: 2026-08-20 | Code: F | equity_swap_involved: false | shares_owned_after: 3,853.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting.
• F2: Includes 3,425 shares of common stock subject to vesting restrictions. The shares were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 171 shares vest on each of November 20, 2026, and March 6, 2027, 1,250 shares vest on May 15, 2027, 171 shares vest on each of May 20, 2027, August 20, 2027, November 20, 2027, March 6, 2028, May 20, 2028, August 20, 2028, November 20, 2028, and March 6, 2029, 178 shares vest on May 20, 2029, 93 shares vest on each of August 20, 2029 and November 20, 2029, and 101 shares vest on March 6, 2030. Vesting is contingent upon the reporting person's continued service with the Company through each applicable vesting date.